1. Home
  2. ITOS vs LEGH Comparison

ITOS vs LEGH Comparison

Compare ITOS & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • LEGH
  • Stock Information
  • Founded
  • ITOS 2011
  • LEGH 2005
  • Country
  • ITOS United States
  • LEGH United States
  • Employees
  • ITOS N/A
  • LEGH N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • LEGH Homebuilding
  • Sector
  • ITOS Health Care
  • LEGH Consumer Discretionary
  • Exchange
  • ITOS Nasdaq
  • LEGH Nasdaq
  • Market Cap
  • ITOS 568.2M
  • LEGH 678.2M
  • IPO Year
  • ITOS 2020
  • LEGH 2018
  • Fundamental
  • Price
  • ITOS $14.80
  • LEGH $25.55
  • Analyst Decision
  • ITOS Strong Buy
  • LEGH Buy
  • Analyst Count
  • ITOS 5
  • LEGH 2
  • Target Price
  • ITOS $32.60
  • LEGH $29.00
  • AVG Volume (30 Days)
  • ITOS 330.6K
  • LEGH 42.8K
  • Earning Date
  • ITOS 11-05-2024
  • LEGH 08-08-2024
  • Dividend Yield
  • ITOS N/A
  • LEGH N/A
  • EPS Growth
  • ITOS N/A
  • LEGH N/A
  • EPS
  • ITOS N/A
  • LEGH 2.18
  • Revenue
  • ITOS $35,000,000.00
  • LEGH $169,389,000.00
  • Revenue This Year
  • ITOS $271.18
  • LEGH N/A
  • Revenue Next Year
  • ITOS N/A
  • LEGH $7.58
  • P/E Ratio
  • ITOS N/A
  • LEGH $11.73
  • Revenue Growth
  • ITOS N/A
  • LEGH N/A
  • 52 Week Low
  • ITOS $8.20
  • LEGH $17.67
  • 52 Week High
  • ITOS $18.75
  • LEGH $29.31
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 36.33
  • LEGH 44.74
  • Support Level
  • ITOS $17.12
  • LEGH $25.44
  • Resistance Level
  • ITOS $17.44
  • LEGH $26.96
  • Average True Range (ATR)
  • ITOS 0.88
  • LEGH 0.67
  • MACD
  • ITOS -0.21
  • LEGH -0.18
  • Stochastic Oscillator
  • ITOS 4.03
  • LEGH 4.12

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About LEGH Legacy Housing Corporation (TX)

Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to customers to facilitate the sale of homes.

Share on Social Networks: